T-Charge™ Manufacturing of the Anti-BCMA CAR-T, Durcabtagene Autoleucel (PHE885), Promotes Expansion and Persistence of CAR-T Cells with High TCR Repertoire DiversityShuntaro Ikegawa,Adam S. Sperling,Michela Ansuinelli,Sarah Nikiforow,David Quinn,Dexiu Bu,Jennifer Mataraza,David Pearson,Lawrence Rispoli,Marc A Credi, Nina Orwitz,Yohei Arihara,Rao Prabhala,Lakshmi Bhavani Potluri,Carol Reynolds,Serena De Vita,Nikhil C Munshi,Jerome RitzBlood（2023）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
